Journal of Nutrition Animal Diets/Enrichment Products...

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, C.-c.
Right arrow Articles by Hsieh, C.-h.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, C.-c.
Right arrow Articles by Hsieh, C.-h.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:3245-3249, December 2004


Biochemical and Molecular Actions of Nutrients

Five Cysteine-Containing Compounds Delay Diabetic Deterioration in Balb/cA Mice1

Cheng-chin Hsu, Hsiu-fang Yen, Mei-chin Yin2, Chiung-man Tsai and Chang-hung Hsieh

Department of Nutritional Science, Chungshan Medical University, Taichung City, Taiwan

2To whom correspondence should be addressed. E-mail: mcyin{at}csmu.edu.tw.

The effects of n-acetyl cysteine (NAC), s-allyl cysteine (SAC), s-ethyl cysteine, s-methyl cysteine and s-propyl cysteine (SPC) activity on Balb/cA mice against diabetic complications were examined. These complications included hyperglycemia, hyperlipidemia, oxidation stress, blood coagulation, and cytokine imbalance. To induce diabetes, mice were treated with streptozotocin i.p. for 5 consecutive days. Five cysteine-containing compounds at 1 g/L were added to the drinking water. After intake of the 5 cysteine-containing agents for 4 wk, body weight loss, plasma concentrations of glucose and insulin, and fibronectin levels were improved (P < 0.05) in diabetic mice. The administration of these agents restored the glutathione level (P < 0.05), reduced the loss of catalase and glutathione peroxidase activities in kidney and liver (P < 0.05), and decreased glucose-induced lipid oxidation, as assessed by malondialdehyde formation (P < 0.05). In all diabetic mice, the intake of these agents reduced triglyceride levels in plasma and liver (P < 0.05); however, only NAC, SAC and SPC treatments reduced cholesterol level in liver (P < 0.05). These cysteine-containing agents elevated the activity of 2 fibrinolytic factors, protein C and antithrombin III (P < 0.05). The overexpression of interleukin-6 and tumor necrosis factor-{alpha} in diabetic mice was suppressed by the intake of the 5 cysteine-containing agents (P < 0.05). Via their antioxidant activities, the 5 compounds effectively improved glycemic control, delayed oxidation damage, downregulated inflammatory cytokines, and enhanced anticoagulant activity in diabetic mice. These data support the multiple roles of these agents as potential protective agents for delaying diabetic deterioration.


KEY WORDS: • diabetes • cysteine-containing agents • coagulation • oxidation • interleukin-6




This article has been cited by other articles:


Home page
J. Nutr.Home page
Y.-P. Lei, H.-W. Chen, L.-Y. Sheen, and C.-K. Lii
Diallyl Disulfide and Diallyl Trisulfide Suppress Oxidized LDL-Induced Vascular Cell Adhesion Molecule and E-Selectin Expression through Protein Kinase A- and B-Dependent Signaling Pathways
J. Nutr., June 1, 2008; 138(6): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Wassef, R. Haenold, A. Hansel, N. Brot, S. H. Heinemann, and T. Hoshi
Methionine Sulfoxide Reductase A and a Dietary Supplement S-Methyl-L-Cysteine Prevent Parkinson's-Like Symptoms
J. Neurosci., November 21, 2007; 27(47): 12808 - 12816.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Wiederkehr and C. B. Wollheim
Minireview: Implication of Mitochondria in Insulin Secretion and Action
Endocrinology, June 1, 2006; 147(6): 2643 - 2649.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. H. Baker
Comparative Species Utilization and Toxicity of Sulfur Amino Acids
J. Nutr., June 1, 2006; 136(6): 1670S - 1675S.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]